Skip to main content
Top
Published in: Clinical Rheumatology 12/2020

01-12-2020 | Sarcopenia | Original Article

Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients

Authors: Edoardo Rosato, Antonietta Gigante, Andrea Iacolare, Annalisa Villa, Maria Ludovica Gasperini, Maurizio Muscaritoli

Published in: Clinical Rheumatology | Issue 12/2020

Login to get access

Abstract

Introduction/objectives

This study aims to evaluate the role of fat free mass index (FFMI) and phase angle (PhA) as markers to predict occurrence of new digital ulcers in systemic sclerosis (SSc) patients.

Methods

Body composition evaluation from bioelectrical impedance and clinical assessment were performed in SSc patients at enrollment and after 12 months follow-up.

Results

Seventy-nine SSc patients (67 female) with a mean age of 53 ± 13 years were enrolled. In SSc patients with a digital ulcers history, FFMI value is lower (p < 0.05) and phase angle (PhA) value is higher (p < 0.01) than SSc patients without a digital ulcers history. After 12 months of follow-up, 30 patients (38%) presented at least one new episode of digital ulcers. Patients with reduced FFMI had a relative risk of 6.7 for new digital ulcers (CI 2.1–21.8, p < 0.001). Patients with reduced PhA had a relative risk of 10.1 for new digital ulcers (CI 3.5–29.5, p < 0.0001). In multivariate analysis, FFMI and PhA were associated with major vascular complication (digital ulcers, pulmonary arterial hypertension, and scleroderma renal crisis). FFMI loss, assessed as delta between follow-up and baseline, is higher in SSc with short duration (≤ 3 years) than SSc patients with long duration [0.4 (0–0.50) vs − 0.10 (− 0.2–0)].

Conclusion

In SSc patients, reduction of the FFMI and PhA represents after 12 months a risk factor for development of new digital ulcers and major vascular complication.
Key Points
Fat free mass index represents a risk factor for development of digital ulcers
Phase angle represents a risk factor for development of digital ulcers
Body compositions in systemic sclerosis are a marker of activity disease
Literature
1.
go back to reference Campbell PM, LeRoy EC (1975) Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 4:351–368CrossRefPubMed Campbell PM, LeRoy EC (1975) Pathogenesis of systemic sclerosis: a vascular hypothesis. Semin Arthritis Rheum 4:351–368CrossRefPubMed
3.
go back to reference Marighela TF, Genaro Pde S, Pinheiro MM, Szejnfeld VL, Kayser C (2013) Risk factors for body composition abnormalities in systemic sclerosis. Clin Rheumatol 32:1037–1044CrossRefPubMed Marighela TF, Genaro Pde S, Pinheiro MM, Szejnfeld VL, Kayser C (2013) Risk factors for body composition abnormalities in systemic sclerosis. Clin Rheumatol 32:1037–1044CrossRefPubMed
4.
go back to reference Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, Riemekasten G, Müller-Werdan U, Norman K (2018) Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis. Nutrition 55-56:51–55CrossRefPubMed Siegert E, March C, Otten L, Makowka A, Preis E, Buttgereit F, Riemekasten G, Müller-Werdan U, Norman K (2018) Prevalence of sarcopenia in systemic sclerosis: assessing body composition and functional disability in patients with systemic sclerosis. Nutrition 55-56:51–55CrossRefPubMed
5.
go back to reference Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U, Haeupl T, Hanke K, Hensel-Wiegel K, Ebert H, Ziemer S, Ladner UM, Pirlich M, Burmester GR, Riemekasten G (2010) Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957CrossRefPubMed Krause L, Becker MO, Brueckner CS, Bellinghausen CJ, Becker C, Schneider U, Haeupl T, Hanke K, Hensel-Wiegel K, Ebert H, Ziemer S, Ladner UM, Pirlich M, Burmester GR, Riemekasten G (2010) Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis. Ann Rheum Dis 69:1951–1957CrossRefPubMed
6.
go back to reference Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C (2018) Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. Autoimmun Rev 17:155–164CrossRefPubMed Giuggioli D, Manfredi A, Lumetti F, Colaci M, Ferri C (2018) Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature. Autoimmun Rev 17:155–164CrossRefPubMed
7.
go back to reference Caramaschi P, Martinelli N, Volpe A, Pieropan S, Tinazzi I, Patuzzo G, Mahamid H, Bambara LM, Biasi D (2009) A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost. Clin Rheumatol 28:807–813CrossRefPubMed Caramaschi P, Martinelli N, Volpe A, Pieropan S, Tinazzi I, Patuzzo G, Mahamid H, Bambara LM, Biasi D (2009) A score of risk factors associated with ischemic digital ulcers in patients affected by systemic sclerosis treated with iloprost. Clin Rheumatol 28:807–813CrossRefPubMed
8.
go back to reference Rosato E, Barbano B, Gigante A, Molinaro I, Quarta S, Pisarri S, Amoroso A, Cianci R, Salsano F (2014) Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis. Arthritis Care Res (Hoboken) 66:1380–1385CrossRef Rosato E, Barbano B, Gigante A, Molinaro I, Quarta S, Pisarri S, Amoroso A, Cianci R, Salsano F (2014) Increased intrarenal arterial stiffness may predict the occurrence of new digital ulcers in systemic sclerosis. Arthritis Care Res (Hoboken) 66:1380–1385CrossRef
9.
go back to reference van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, Riemekasten G, Clements PJ, Denton CP, Distler O, Allanore Y, Furst DE, Gabrielli A, Mayes MD, van Laar JM, Seibold JR, Czirjak L, Steen VD, Inanc M, Kowal-Bielecka O, Müller-Ladner U, Valentini G, Veale DJ, Vonk MC, Walker UA, Chung L, Collier DH, Csuka ME, Fessler BJ, Guiducci S, Herrick A, Hsu VM, Jimenez S, Kahaleh B, Merkel PA, Sierakowski S, Silver RM, Simms RW, Varga J, Pope JE (2013) 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. Arthritis Rheum 65:2737–2747CrossRefPubMedPubMedCentral
10.
go back to reference LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15:202–205PubMed
11.
go back to reference Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22:1281–1285PubMed
12.
go back to reference Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed Medsger TA Jr, Silman AJ, Steen VD et al (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26:2159–2167PubMed
13.
go back to reference Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76:270–276CrossRefPubMed Valentini G, Iudici M, Walker UA, Jaeger VK, Baron M, Carreira P, Czirják L, Denton CP, Distler O, Hachulla E, Herrick AL, Kowal-Bielecka O, Pope J, Müller-Ladner U, Riemekasten G, Avouac J, Frerix M, Jordan S, Minier T, Siegert E, Ong VH, Vettori S, Allanore Y (2017) The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index. Ann Rheum Dis 76:270–276CrossRefPubMed
14.
go back to reference Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, Conforti ML, Kaloudi O, Nacci F, Sacu O, Candelieri A, Pignone A, Rasero L, Conforti D, Matucci-Cerinic M (2010) Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 49:1374–1382CrossRef Amanzi L, Braschi F, Fiori G, Galluccio F, Miniati I, Guiducci S, Conforti ML, Kaloudi O, Nacci F, Sacu O, Candelieri A, Pignone A, Rasero L, Conforti D, Matucci-Cerinic M (2010) Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. Rheumatology (Oxford) 49:1374–1382CrossRef
15.
go back to reference Cederholm T, Bosaeus I, Barazzoni R, Bauer J, van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, de van der Schueren MAE, Singer P (2015) Diagnostic criteria for malnutrition: an ESPEN consensus statement. Clin Nutr 34:335–340CrossRefPubMed Cederholm T, Bosaeus I, Barazzoni R, Bauer J, van Gossum A, Klek S, Muscaritoli M, Nyulasi I, Ockenga J, Schneider SM, de van der Schueren MAE, Singer P (2015) Diagnostic criteria for malnutrition: an ESPEN consensus statement. Clin Nutr 34:335–340CrossRefPubMed
16.
go back to reference Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Fanelli FR, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29:154–159CrossRefPubMed Muscaritoli M, Anker SD, Argilés J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P, Fearon KC, Laviano A, Maggio M, Fanelli FR, Schneider SM, Schols A, Sieber CC (2010) Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 29:154–159CrossRefPubMed
17.
go back to reference Caimmi C, Caramaschi P, Venturini A, Bertoldo E, Vantaggiato E, Viapiana O, Ferrari M, Lippi G, Frulloni L, Rossini M (2018) Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis. Clin Rheumatol 37:987–997CrossRefPubMed Caimmi C, Caramaschi P, Venturini A, Bertoldo E, Vantaggiato E, Viapiana O, Ferrari M, Lippi G, Frulloni L, Rossini M (2018) Malnutrition and sarcopenia in a large cohort of patients with systemic sclerosis. Clin Rheumatol 37:987–997CrossRefPubMed
18.
go back to reference Spanjer MJ, Bultink IEM, de van der Schueren MAE, Voskuyl AE (2017) Prevalence of malnutrition and validation of bioelectrical impedance analysis for the assessment of body composition in patients with systemic sclerosis. Rheumatology (Oxford) 56:1008–1012CrossRef Spanjer MJ, Bultink IEM, de van der Schueren MAE, Voskuyl AE (2017) Prevalence of malnutrition and validation of bioelectrical impedance analysis for the assessment of body composition in patients with systemic sclerosis. Rheumatology (Oxford) 56:1008–1012CrossRef
19.
go back to reference Matsubara Y, Matsumoto T, Aoyagi Y, Tanaka S, Okadome J, Morisaki K, Shirabe K, Maehara Y (2015) Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg 61:945–950CrossRefPubMed Matsubara Y, Matsumoto T, Aoyagi Y, Tanaka S, Okadome J, Morisaki K, Shirabe K, Maehara Y (2015) Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia. J Vasc Surg 61:945–950CrossRefPubMed
20.
go back to reference Brown JC, Harhay MO, Harhay MN (2016) Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle 7:290–298CrossRefPubMed Brown JC, Harhay MO, Harhay MN (2016) Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle 7:290–298CrossRefPubMed
22.
go back to reference Hughes M, Herrick AL (2017) Digital ulcers in systemic sclerosis. Rheumatology (Oxford) 56:14–25CrossRef Hughes M, Herrick AL (2017) Digital ulcers in systemic sclerosis. Rheumatology (Oxford) 56:14–25CrossRef
24.
go back to reference Díaz BB, González DA, Gannar F, Pérez MCR, de León AC (2018) Myokines, physical activity, insulin resistance and autoimmune diseases. Immunol Lett 203:1–5CrossRefPubMed Díaz BB, González DA, Gannar F, Pérez MCR, de León AC (2018) Myokines, physical activity, insulin resistance and autoimmune diseases. Immunol Lett 203:1–5CrossRefPubMed
25.
go back to reference Gigante A, Margiotta D, Navarini L, Barbano B, Gasperini ML, D'Agostino C, Amoroso A, Afeltra A, Rosato E (2018) Serum level of endostatin and digital ulcers in systemic sclerosis patients. Int Wound J 15:424–428CrossRefPubMedPubMedCentral Gigante A, Margiotta D, Navarini L, Barbano B, Gasperini ML, D'Agostino C, Amoroso A, Afeltra A, Rosato E (2018) Serum level of endostatin and digital ulcers in systemic sclerosis patients. Int Wound J 15:424–428CrossRefPubMedPubMedCentral
26.
go back to reference Cheng Q, Hu J, Yang P, Cao X, Deng X, Yang Q, Liu Z, Yang S, Goswami R, Wang Y, Luo T, Liao K, Li Q (2017) Sarcopenia is independently associated with diabetic foot disease. Sci Rep 7:8372CrossRefPubMedPubMedCentral Cheng Q, Hu J, Yang P, Cao X, Deng X, Yang Q, Liu Z, Yang S, Goswami R, Wang Y, Luo T, Liao K, Li Q (2017) Sarcopenia is independently associated with diabetic foot disease. Sci Rep 7:8372CrossRefPubMedPubMedCentral
27.
go back to reference Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107:931–936CrossRefPubMedPubMedCentral Lieffers JR, Bathe OF, Fassbender K, Winget M, Baracos VE (2012) Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 107:931–936CrossRefPubMedPubMedCentral
28.
go back to reference Viertel M, Bock C, Reich M, Löser S, Plauth M (2019) Performance of CT-based low skeletal muscle index, low mean muscle attenuation, and bioelectric impedance derived low phase angle in the detection of an increased risk of nutrition related mortality. Clin Nutr 38:2375–2380CrossRefPubMed Viertel M, Bock C, Reich M, Löser S, Plauth M (2019) Performance of CT-based low skeletal muscle index, low mean muscle attenuation, and bioelectric impedance derived low phase angle in the detection of an increased risk of nutrition related mortality. Clin Nutr 38:2375–2380CrossRefPubMed
29.
go back to reference Selberg O, Selberg D (2002) Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 86:509–516CrossRefPubMed Selberg O, Selberg D (2002) Norms and correlates of bioimpedance phase angle in healthy human subjects, hospitalized patients, and patients with liver cirrhosis. Eur J Appl Physiol 86:509–516CrossRefPubMed
30.
go back to reference Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi GA, Michelassi C (1996) Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 50:2103–2108CrossRefPubMed Maggiore Q, Nigrelli S, Ciccarelli C, Grimaldi C, Rossi GA, Michelassi C (1996) Nutritional and prognostic correlates of bioimpedance indexes in hemodialysis patients. Kidney Int 50:2103–2108CrossRefPubMed
31.
go back to reference Faisy C, Rabbat A, Kouchakji B, Laaban JP (2000) Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med 26:518–525CrossRefPubMed Faisy C, Rabbat A, Kouchakji B, Laaban JP (2000) Bioelectrical impedance analysis in estimating nutritional status and outcome of patients with chronic obstructive pulmonary disease and acute respiratory failure. Intensive Care Med 26:518–525CrossRefPubMed
32.
go back to reference Tanaka S, Ando K, Kobayashi K et al (2019) Low bioelectrical impedance phase angle is a significant risk factor for frailty. Biomed Res Int:6283153 Tanaka S, Ando K, Kobayashi K et al (2019) Low bioelectrical impedance phase angle is a significant risk factor for frailty. Biomed Res Int:6283153
34.
go back to reference Gigante A, Gasperini ML, Rosato E, Navarini L, Margiotta D, Afeltra A, Muscaritoli M (2020) Phase angle could be a marker of microvascular damage in systemic sclerosis. Nutrition 73:110730CrossRefPubMed Gigante A, Gasperini ML, Rosato E, Navarini L, Margiotta D, Afeltra A, Muscaritoli M (2020) Phase angle could be a marker of microvascular damage in systemic sclerosis. Nutrition 73:110730CrossRefPubMed
35.
go back to reference Baron M, Hudson M, Steele R, Canadian Scleroderma Research Group (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36:2737–2743CrossRefPubMed Baron M, Hudson M, Steele R, Canadian Scleroderma Research Group (2009) Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol 36:2737–2743CrossRefPubMed
36.
go back to reference Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, Haehling S, Coats AJS, Anker SD (2019) Sarcopenia: a time for action. An SCWD Position Paper J Cachexia Sarcopenia Muscle 10:956–996CrossRefPubMed Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, Haehling S, Coats AJS, Anker SD (2019) Sarcopenia: a time for action. An SCWD Position Paper J Cachexia Sarcopenia Muscle 10:956–996CrossRefPubMed
Metadata
Title
Reduction of fat free mass index and phase angle is a risk factor for development digital ulcers in systemic sclerosis patients
Authors
Edoardo Rosato
Antonietta Gigante
Andrea Iacolare
Annalisa Villa
Maria Ludovica Gasperini
Maurizio Muscaritoli
Publication date
01-12-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 12/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05141-0

Other articles of this Issue 12/2020

Clinical Rheumatology 12/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.